AT226880B - Verfahren zur Stabilisierung eines Impfstoffes gegen Poliomyelitis - Google Patents

Verfahren zur Stabilisierung eines Impfstoffes gegen Poliomyelitis

Info

Publication number
AT226880B
AT226880B AT208061A AT208061A AT226880B AT 226880 B AT226880 B AT 226880B AT 208061 A AT208061 A AT 208061A AT 208061 A AT208061 A AT 208061A AT 226880 B AT226880 B AT 226880B
Authority
AT
Austria
Prior art keywords
stabilizing
vaccine against
against poliomyelitis
poliomyelitis
vaccine
Prior art date
Application number
AT208061A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of AT226880B publication Critical patent/AT226880B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
AT208061A 1960-03-30 1961-03-13 Verfahren zur Stabilisierung eines Impfstoffes gegen Poliomyelitis AT226880B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US226880XA 1960-03-30 1960-03-30

Publications (1)

Publication Number Publication Date
AT226880B true AT226880B (de) 1963-04-10

Family

ID=21810913

Family Applications (1)

Application Number Title Priority Date Filing Date
AT208061A AT226880B (de) 1960-03-30 1961-03-13 Verfahren zur Stabilisierung eines Impfstoffes gegen Poliomyelitis

Country Status (1)

Country Link
AT (1) AT226880B (de)

Similar Documents

Publication Publication Date Title
CH423789A (de) Verfahren zur Herstellung eines Benzimidazols
AT267066B (de) Verfahren zur Herstellung eines Babynahrungsmittels
CH456549A (de) Verfahren zur Herstellung eines Katalysators
CH456159A (de) Verfahren zur Emulsionspolymerisation
CH457110A (de) Verfahren zur Herstellung eines Nahrungsmittels
AT288340B (de) Verfahren zur Herstellung von Aminonitroalkanen
CH469093A (de) Verfahren zur Herstellung eines neuen Impfstoffes gegen Panleucopenia
CH399538A (de) Mehrfach-Magnetkopf und Verfahren zur Herstellung eines solchen Kopfes
CH447609A (de) Verfahren zur Herstellung eines homogenen Tetrapolymers und dessen Verwendung
CH448516A (de) Verfahren zur Herstellung eines Filmbildners
CH413237A (de) Verfahren zur Herstellung einer Wasser-in-Öl-Emulsion
CH395094A (de) Verfahren zur Herstellung von 6-Chlor-benzisothiazolon
CH396854A (de) Verfahren zur Herstellung eines Siliciumfilms
CH396874A (de) Verfahren zur Herstellung von Chlorbenzylisothiuroniumchloriden
AT226880B (de) Verfahren zur Stabilisierung eines Impfstoffes gegen Poliomyelitis
AT226881B (de) Verfahren zur Stabilisierung eines Impfstoffes gegen Poliomyelitis
CH408285A (de) Verfahren zum Konservieren eines Impfstoffes
CH394215A (de) Verfahren zur Herstellung von Aminoketonderivaten
CH392779A (fr) Verfahren zur Herstellung eines Heilmittels gegen Polycythaemie
CH379180A (de) Verfahren zur Herstellung eines Reissverschlusses
CH426454A (de) Verfahren zur Herstellung eines Nahrungsmittels
AT243998B (de) Verfahren zur Herstellung eines C40-Diindiols
AT247518B (de) Verfahren zur Herstellung einer Poliomyelitisvaccine
CH338961A (de) Verfahren zur Herstellung eines Gebäudes
CH393305A (de) Verfahren zur Herstellung von Dimethallylphthalaten